Rhumbline Advisers Eton Pharmaceuticals, Inc. Transaction History
Rhumbline Advisers
- $113 Billion
- Q2 2025
A detailed history of Rhumbline Advisers transactions in Eton Pharmaceuticals, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 36,594 shares of ETON stock, worth $779,818. This represents 0.0% of its overall portfolio holdings.
Number of Shares
36,594Holding current value
$779,818% of portfolio
0.0%Shares
5 transactions
Others Institutions Holding ETON
# of Institutions
87Shares Held
15MCall Options Held
242KPut Options Held
11.8K-
Opaleye Management Inc. Boston, MA2.86MShares$60.9 Million9.75% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA2.03MShares$43.3 Million2.49% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.31MShares$28 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT1.18MShares$25.1 Million0.73% of portfolio
-
Geode Capital Management, LLC Boston, MA593KShares$12.6 Million0.0% of portfolio
About Eton Pharmaceuticals, Inc.
- Ticker ETON
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,297,000
- Market Cap $539M
- Description
- Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for th...